Literature DB >> 15111519

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Sarah Wild1, Gojka Roglic, Anders Green, Richard Sicree, Hilary King.   

Abstract

OBJECTIVE: The goal of this study was to estimate the prevalence of diabetes and the number of people of all ages with diabetes for years 2000 and 2030. RESEARCH DESIGN AND METHODS: Data on diabetes prevalence by age and sex from a limited number of countries were extrapolated to all 191 World Health Organization member states and applied to United Nations' population estimates for 2000 and 2030. Urban and rural populations were considered separately for developing countries.
RESULTS: The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030. The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men. The urban population in developing countries is projected to double between 2000 and 2030. The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age.
CONCLUSIONS: These findings indicate that the "diabetes epidemic" will continue even if levels of obesity remain constant. Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.

Entities:  

Mesh:

Year:  2004        PMID: 15111519     DOI: 10.2337/diacare.27.5.1047

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  2000 in total

1.  Editorial: "Old lamps for new".

Authors:  C M Conway
Journal:  Br J Anaesth       Date:  1975-08       Impact factor: 9.166

2.  Fasting Glucose and the Risk of Depressive Symptoms: Instrumental-Variable Regression in the Cardiovascular Risk in Young Finns Study.

Authors:  Karolina Wesołowska; Marko Elovainio; Taina Hintsa; Markus Jokela; Laura Pulkki-Råback; Niina Pitkänen; Jari Lipsanen; Janne Tukiainen; Leo-Pekka Lyytikäinen; Terho Lehtimäki; Markus Juonala; Olli Raitakari; Liisa Keltikangas-Järvinen
Journal:  Int J Behav Med       Date:  2017-12

Review 3.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

4.  Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial.

Authors:  Whady Hueb; Neuza Lopes; Paulo R Soares; Bernard J Gersh; Eduardo Gomes Lima; Ricardo D Oliveira Vieira; Cibele Larrosa Garzillo; Rosa Rhami Garcia; Alexandre Costa Pereira; Celia Maria Strunz; Claudio Meneguetti; Jeane Tsutsui; Jose Parga; Pedro Lemos; Alexandre Hueb; Augusto Ushida; Raul Maranhão; Dalton A Chamone; Jose Af Ramires
Journal:  BMC Cardiovasc Disord       Date:  2010-09-29       Impact factor: 2.298

Review 5.  Hyperspectral imaging in diabetic foot wound care.

Authors:  Dmitry Yudovsky; Aksone Nouvong; Laurent Pilon
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

6.  Diabetes in the desert: what do patients know about the heat?

Authors:  Adrienne A Nassar; Raymond D Childs; Mary E Boyle; Kimberly A Jameson; Margaret Fowke; Ken R Waters; Michael J Hovan; Curtiss B Cook
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

7.  Predictors of short-term diabetes remission after laparoscopic Roux-en-Y gastric bypass.

Authors:  Gianluca Iacobellis; Chengyu Xu; Rafael E Campo; Nestor F De La Cruz-Munoz
Journal:  Obes Surg       Date:  2015-05       Impact factor: 4.129

8.  Inpatient Management of Diabetes Mellitus among Noncritically Ill Patients at University Hospital of Puerto Rico.

Authors:  Myriam Zaydee Allende-Vigo; Rafael A González-Rosario; Loida González; Viviana Sánchez; Mónica A Vega; Milliette Alvarado; Raul O Ramón
Journal:  Endocr Pract       Date:  2014-05       Impact factor: 3.443

9.  Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population.

Authors:  A S Meijnikman; C E M De Block; E Dirinck; A Verrijken; I Mertens; B Corthouts; L F Van Gaal
Journal:  Int J Obes (Lond)       Date:  2017-07-19       Impact factor: 5.095

10.  Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.

Authors:  Justyna Siwy; Joost P Schanstra; Angel Argiles; Stephan J L Bakker; Joachim Beige; Petr Boucek; Korbinian Brand; Christian Delles; Flore Duranton; Beatriz Fernandez-Fernandez; Marie-Luise Jankowski; Mohammad Al Khatib; Thomas Kunt; Maria Lajer; Ralf Lichtinghagen; Morten Lindhardt; David M Maahs; Harald Mischak; William Mullen; Gerjan Navis; Marina Noutsou; Alberto Ortiz; Frederik Persson; John R Petrie; Johannes M Roob; Peter Rossing; Piero Ruggenenti; Ivan Rychlik; Andreas L Serra; Janet Snell-Bergeon; Goce Spasovski; Olivera Stojceva-Taneva; Matias Trillini; Heiko von der Leyen; Brigitte M Winklhofer-Roob; Petra Zürbig; Joachim Jankowski
Journal:  Nephrol Dial Transplant       Date:  2014-03-02       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.